Healthcare -
Biotechnology - NASDAQ - US
$ 46.86
-4.01 %
$ 2.02 B
Market Cap
-10.7
P/E
SLNO - CASH FROM INVESTING ACTIVITIES
Cash from Investing Activities SLNO - Soleno Therapeutics, Inc.
0
LAST VALUE
41.42%
2 YEAR CAGR
14.87%
5 YEAR CAGR
7.18%
10 YEAR CAGR